Furosemide Controlled Release (scPharmaceuticals)

N/A

Report date: 2025/03/17 15:02:19

Base Information

Drug NameFurosemide Controlled Release (scPharmaceuticals)
Drug Alias NameFuroscix Infusorsc2Wear furosemide InfusorFurosemide InjectionFurosemide Micropump PatchFuroscix +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium-(potassium)-chloride cotransporter 2 inhibitorsGamma-aminobutyric acid A receptor antagonists
TargetsSodium-(potassium)-chloride cotransporter 2Gamma-aminobutyric acid A receptor
Therapy Area/IndicationsEdemaHeart FailureRenal Insufficiency, Chronic
Global Approved IndicationsHeart Failure
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2022/10/07
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesScpharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesScpharmaceuticals Inc
Inactive CompaniesUniversity of Texas Southwestern Medical CenterJohns Hopkins University
Active IndicationsEdemaHeart FailureRenal Insufficiency, Chronic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A